Proxima Capital Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
14
- Investments
-
116
- Portfolio
-
81
- Exits
-
9
Proxima Capital General Information
Company Description
Founded in 2015, Proxima Capital is a venture capital firm headquartered in Shanghai, China. The firm invests in seed-to-growth-stage companies operating in the healthcare industry such as medical devices, diagnostics, pharmaceuticals, biotechnology and healthcare services.
Business Details
Investor Status
Primary Investor Type
Corporate Office
- Villa 2, Lane 695
- Jianguo Road (West)
- Shanghai
- China
Proxima Capital Investments (116)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| BCI-Sonics | 22-Sep-2026 | Early Stage VC | Diagnostic Equipment | Generating Revenue | ||
| DeliNova Therapeutics | 10-Jun-2026 | Drug Discovery | Generating Revenue | |||
| Kechuang Biotechnology | 02-Jun-2026 | Medical Supplies | Generating Revenue | |||
| Intellizon | 14-May-2026 | Therapeutic Devices | Generating Revenue | |||
| Bluesail Surgical | 06-Feb-2026 | Surgical Devices | Generating Revenue | |||
| Rayertech | 01-Dec-2025 | Therapeutic Devices | Generating Revenue | |||
| Shengxin Medical | 21-Nov-2025 | Surgical Devices | Generating Revenue | |||
| Brise Pharma | 17-Nov-2025 | Drug Discovery | Clinical Trials - Phase 2 | |||
| BridGene Biosciences | 16-Oct-2025 | Later Stage VC | Drug Discovery | Clinical Trials - Phase 1 | ||
| Rapafusyn Pharmaceuticals | 04-Sep-2025 | Later Stage VC | Drug Discovery | Pre-Clinical Trials |
Proxima Capital Exits (9)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Crabyter | 03-Jun-2024 | Secondary Transaction - Private | |
| Shengxin Medical | 30-Apr-2024 | ||
| Cryofocus | 30-Dec-2022 | ||
| Jenscare Biotechnology | 10-Oct-2022 | IPO | |
| Lungshield Medical | 23-Feb-2022 | Secondary Transaction - Private |
Proxima Capital Investments by Industry, Year, and Region
Proxima Capital Co-Investors (123)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| 3E Bioventures (China) | 3 |
|
|
||
| Qiming Venture Partners |
|
|
|||
| Shanghai Lingang Economic Development |
|
|
|||
| Suzhou Oriza Holdings Corporation |
|
|
|||
| Legend Capital |
|
|
Proxima Capital FAQs
-
What is Proxima Capital?
Founded in 2015, Proxima Capital is a venture capital firm headquartered in Shanghai, China.
-
When was Proxima Capital founded?
Proxima Capital was founded in 2015.
-
Where is Proxima Capital headquartered?
Proxima Capital is headquartered in Shanghai, China.
-
How many investments has Proxima Capital made?
Proxima Capital has made 116 investments.
-
What has Proxima Capital invested in?
Proxima Capital has made numerous investments in companies like BCI-Sonics, DeliNova Therapeutics, and Kechuang Biotechnology within the Diagnostic Equipment, Drug Discovery, and Medical Supplies industries.
-
What has Proxima Capital invested in recently?
Proxima Capital's latest investment was on 22-Sep-2026 in BCI-Sonics, a company within the Diagnostic Equipment industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process